To unlock the potential from truly innovative science to transform patients’ lives
We create, build and scale companies around exceptional science to create a diversified portfolio of 20-25 globally leading healthcare businesses
A diversified portfolio across clinical stages
Making a positive contribution
We are committed to managing our business in a sustainable way, investing responsibly, and supporting our portfolio companies in making positive contributions to society by developing treatments that will make a difference to the lives of patients and their families.
2024 Annual Report
Our Annual Report and Accounts 2024 provides an overview of our most recent financial year, as we continue to execute our clear strategy for growth and patient impact.
An expert multi-disciplinary team, attracting world-class talent
We are differentiated by our people, who identify innovative technology and take a commercial approach to building businesses capable of delivering transformational treatments to patients.
